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The development of novel techniques and systems to
study human infectious diseases in both an in vitro and
in vivo settings is always in high demand. Ideally, small
animal models are the most efficient method of studying
human afflictions. This is especially evident in the study
of the human retroviruses, HIV-1 and HTLV-1, in that
current simian animal models, though robust, are often
expensive and difficult to maintain. Recently significant
advances have been made to use human stem cells in
immunocomprimised animals and follow the course of
infection. HTLV-1-infected humanized non-obese dia-
betic severe combined immunodeficiency (HU-NOD/
S C I D )m i c eh a v eb e e ns h o w nb yi n o c u l a t i o no fN O D /
SCID mice with CD34(+) hematopoietic progenitor and
stem cells (CD34(+) HP/HSCs) infected ex vivo with
HTLV-1 [1]. These mice exclusively develop CD4 (+) T-
cell lymphomas with characteristics similar to ATL and
elevated proliferation of infected human stem cells in
t h eb o n em a r r o ww e r eo b s e r v e di nm i c ed e v e l o p i n g
malignancies. We will discuss the results of a panel of
inhibitors against NFkB, cyclin/cdk complexes and Jack/
Stat pathway that effectively inhibit HTLV-1 and Tax
expression in vivo.
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